Tragara Pharmaceuticals, Inc.
Records under this name other than patents Tragara Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 5 of 5 · Back to Tragara Pharmaceuticals, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,120,815 | Solid state forms of macrocyclic kinase inhibitors Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,544,162 | Polymorphic Form of TG02 Formerly held In force · High confidence | In force | High confidence | |
| US 12,043,630 | Polymorphic Form of TG02 for Treating Cancer Formerly held In force · High confidence | In force | High confidence | |
| US 11,865,116 | Treatment of Cancer with TG02 Formerly held In force · High confidence | In force | High confidence | |
| US 8,247,423 | Methods and Compositions for the Treatment of Cancer, Tumors, and Tumor-Related Disorders Formerly held Lapsed on the fee record Ended Aug 21, 2016 · High confidence | Lapsed on the fee record | Ended Aug 21, 2016 | High confidence |